Our findings are consistent with several reports of SXR activating one or another of these targets, but this is the first demonstration of TERE1-mediated endogenous K-2 synthesis switching on a suite of SXR targets in prostate cancer cells. This evidence concerns the gene UBIAD1 and prostate cancer.